<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>CENTRAIS ELETRICAS BRASILEIRAS SA-ELETROBRAS (SPONS ADRS) RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sun, 19 Apr 2026 23:47:45 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/centrais%5Feletricas%5Fbrasileiras%5Fsa%2Deletrobras%5F%28spons%5Fadrs%29%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>CENTRAIS ELETRICAS BRASILEIRAS SA-ELETROBRAS (SPONS ADRS) RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Centrais Eletricas Brasileiras SA-Eletrobras (spons ADRs): So schnitt der Konzern im vergangenen Quartal ab</title><pubDate>Sat, 08 Nov 2025 06:35:07 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/centrais-eletricas-brasileiras-sa-eletrobras-spons-adrs-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15227026</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/centrais_eletricas_brasileiras_sa-eletrobras_(spons_adrs)-aktie">Centrais Eletricas Brasileiras SA-Eletrobras (spons ADRs)</a> hat am 05.11.2025 das Zahlenwerk zum am 30.09.2025 abgelaufenen Jahresviertel vorgestellt.Centrais Eletricas  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/centrais-eletricas-brasileiras-sa-eletrobras-spons-adrs-so-schnitt-der-konzern-im-vergangenen-quartal-ab-15227026</guid></item><item><title>EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients</title><pubDate>Fri, 07 Nov 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/ebr-systems-achieves-first-enrollments-in-the-wise-up-study-for-heart-failure-patients-15219958</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><b><i>The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system.</i></b><p xmlns="http://www.w3.org/1999/xhtml"><b>Key  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/ebr-systems-achieves-first-enrollments-in-the-wise-up-study-for-heart-failure-patients-15219958</guid></item><item><title>EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients</title><pubDate>Fri, 07 Nov 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/ebr-systems-achieves-first-enrollments-in-the-wise-up-study-for-heart-failure-patients-15219990</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><b><i>The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system.</i></b><p xmlns="http://www.w3.org/1999/xhtml"><b>Key  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/ebr-systems-achieves-first-enrollments-in-the-wise-up-study-for-heart-failure-patients-15219990</guid></item></channel></rss>
